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Abstract
Background: Laryngeal dysfunction after thyroid and parathyroid surgery
requires early recognition and a standardized approach for patients that present with voice, swallowing, and breathing issues. The Endocrine Committee
of the American Head and Neck Society (AHNS) convened a panel to define
the terms “immediate vocal fold paralysis” and “partial neural dysfunction”
and to provide clinical consensus statements based on review of the literature, integrated with expert opinion of the group.
Methods: A multidisciplinary expert panel constructed the manuscript and
recommendations for laryngeal dysfunction after thyroid and parathyroid
surgery. A meta-analysis was performed using the literature and published
guidelines. Consensus was achieved using polling and a modified Delphi
approach.
Results: Twenty-two panelists achieved consensus on five statements regarding the role of early identification and standardization of evaluation for
patients with “immediate vocal fold paralysis” and “partial neural dysfunction” after thyroid and parathyroid surgery.
Conclusion: After endorsement by the AHNS Endocrine Section and Quality of Care Committee, it received final approval from the AHNS Council.
KEYWORDS
immediate vocal fold paralysis, laryngeal exam, partial neural dysfunction, recurrent laryngeal
nerve, superior laryngeal nerve

1 | INTRODUCTION
Thyroid and parathyroid surgery requires early recognition
and meticulous dissection to preserve neurophysiologic
function of the recurrent laryngeal nerve (RLN) and its branches. The complex anatomy and physiology of the larynx
can be altered after thyroid surgery with a significant
impact on quality of life1,2. Laryngeal dysfunction can
occur from direct injury to the RLN causing vocal fold
immobility. Additionally, injury to the small branches of
the RLN may result in neural dysfunction with or without
recognizable motion impairment. Injury presents along a
diverse spectrum of symptomatic clinical complaints that
may be associated with minimal or no identifiable abnormality on routine laryngeal examination.
The reported rates of vocal fold paralysis (VFP) after
thyroidectomy are a significant underestimate of its true
incidence.3 A systematic review of 25 000 patients
reported temporary and permanent VFP rates of 9.8%
and 2.3%, respectively. It also reported a range of overall
postoperative VFP as 2.3% to 26% depending on the
method of laryngeal examination.4
The 2017, 5th National Audit of the British Association of Thyroid and Endocrine Surgeons reported a

postoperative VFP rate of 7.8% for first-time thyroid surgery.3 The exact timeframe for the first postoperative
laryngeal examination varies.
In total thyroidectomy, transient and permanent
bilateral vocal fold paralysis (BVFP) rates of 0.7% and
0.3% have been reported.5 In a French study, the incidence of tracheostomy was 0.36% and 30% in patients
sustaining BVFP.6 A retrospective review of 106 773 thyroidectomy patients in California reported a 1.62% tracheostomy rate.7
With an increased awareness of the true scale of VFP
following thyroidectomy comes an appreciation of its
associated morbidity and mortality. A national database
study of 43 515 patients revealed that VFP doubled the
risk of hospital admission for pneumonia, which led to
over three times the risk of dysphagia and a 20-fold risk
of gastrostomy or tracheostomy. Studies also revealed
that long-term mortality from VFP lessened with early
diagnosis and treatment, but never returned to a normal
baseline in matched pair analysis.8
Recognizing VFP as a significant complication,
requiring early diagnosis and intervention, is vital to minimizing associated morbidity and maintaining an optimal
patient-doctor relationship. There is significant
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psychosocial morbidity with VFP that can contribute to
frustration, isolation, fear, and altered self-identity for
patients.9 Failure to communicate and manage this complication adequately will engender greater patient mistrust and dissatisfaction, leading to both increased
complaints and litigation.10
It is also important to recognize that laryngeal dysfunction is more complex than just VFP. Laryngeal dysfunction encompasses sensory and motor dysfunction
that can lead to symptoms of cough, globus sensation,

and dysphagia. In line with early diagnosis of VFP, recognition of the varying states of laryngeal dysfunction in
the presence or absence of VFP will improve patient satisfaction and decrease morbidity.

1.1 | Immediate vocal fold paralysis
The currently used definitions for VFP, as “temporary
and permanent,” are antiquated clinical concepts when

2 weeks to 2 months visit (or first postoperative visit)
After thyroid and/or parathyroid surgery with chief complaint
of voice, swallowing or breathing problem:

Immediate vocal fold paralysis OR
Partial neural dysfunction
(efferent RLN injury, afferent RLN injury, efferent SLN injury)

Laryngeal examination
(Fiberoptic laryngoscopy)

Efferent RLN injury
(paralysis, paresis)

Efferent SLN injury
(Pitch changes, dysphagia)

Vocal cord immobility

Medial rotation of arytenoid

Glottic insufficiency

Asymmetric lengthening of

Afferent RLN injury
(cough, globus, dysphagia)

Normal laryngoscopy

vocal cord

Otolaryngology or laryngology con sultation and evaluation for t reatment consideration
Factors to consider in decision for treatment

F I G U R E 1 Overview of identification of immediate vocal fold paralysis and partial neural dysfunction to treatment [Color figure can
be viewed at wileyonlinelibrary.com]
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Symptoms

Age

Risk for aspiration
Patient's desire
for voice
outcome

Intraoperative
details

Otolaryngology/laryngology, SLP, and individual patient counseling
Treatment is warranted independent of prognosis of vocal cord recovery

Treatment options

Voice and swallow therapy

FIGURE 1

Early medialization

Further tests and surveillance

(Continued)

managing patients with postoperative laryngeal dysfunction and VFP today. We introduce the definition of
“immediate VFP” in order to encourage and guide early
identification and intervention, which can improve morbidity, and have a significant psychosocial impact for the
patient. Early evaluation and counseling in the “immediate” timeframe is warranted for the aforementioned reason independent of prognosis of vocal fold recovery.
Patients with subjective voice complaints in the immediate postoperative period should be considered for
Otolaryngology-Head and Neck Surgery and Speech Language Pathology evaluation within the first postoperative
visit. The laryngeal examination can take the form of
fiberoptic laryngoscopy and/or stroboscopy.
Furthermore, identification of “immediate VFP” optimizes the surgeon's learning curve, allowing us to learn
best if we are aware of all cases in which our surgery

resulted in any neural dysfunction even if it resolves
overtime. Early identification of immediate unilateral
VFP allows for earlier counseling and treatment. If
pathology is identified, a careful analysis of associated
risk factors such as patient's age, symptoms, patient's
desire to get assistance, risk of aspiration, mechanism of
injury, and intraoperative electrophysiological data
should be collected to determine the need for treatment.
There is strong evidence that early treatment for unilateral VFP improves outcomes from a voice and aspiration
prevention standpoint8,11-13 (Figure 1).

1.2 | Partial neural dysfunction
RLN and superior laryngeal nerve (SLN) injury are not
an “all or none” phenomenon, since multiple states of
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dysfunction can be recognized by symptomatology. The
efferent and afferent pathways involved in partial neural
dysfunction (PND) include partial RLN dysfunction and
partial or complete SLN dysfunction. These pathologies
can lead to persistent voice and nonvoice-related symptoms exclusive of VFP, including cough, globus sensation, and dysphagia. Stroboscopy should be considered
when fiberoptic laryngoscopy does not reconcile these
symptoms if they occur after surgery. These states of partial, nuanced, dysfunction will require more in-depth and
targeted evaluation, as well as counseling and surveillance, and it is our task to promptly recognize their existence. An experienced Otolaryngologist-Head and Neck
Surgeon and Speech Language Pathologist can consider
treatment options, upon an analysis of risk factors and
discussion with the patient.
In this article, we will define the terms “immediate
postoperative laryngeal dysfunction” and “partial neural
dysfunction” in an attempt to identify subgroups of
patients and optimize evaluation and treatment for
patients with voice, swallowing, and breathing issues
after thyroid and parathyroid surgery.

2 | METHODS
2.1 | Expert panel construction and
process
Panel members were selected to represent endocrine
surgeons from both Otolaryngology-Head and Neck
Surgery and General Surgery, Laryngologists, Endocrinologists and Speech Language Pathologists from North
America and the United Kingdom. Organizations represented include the American Head and Neck Society
Endocrine Section (AHNS-ES), American Academy of
Otolaryngology-Head and Neck Surgery (AAOHNS),
American Association of Endocrine Surgeons (AAES),
American Thyroid Association (ATA), American Association of Clinical Endocrinologists (AACE), and American Laryngological Association (ALA), as well as the
American Bronchoesophagological Association (ABEA)
and British Association of Endocrine and Thyroid Surgeons (BAETS).
The specific goals of the Clinical Consensus Statement
in outline were reviewed with the entire group. The initial
three panel members (VKD, RPT, and GWR) defined the
terms that would undergo consensus development. Candidate statements were proposed in alignment with the Institute of Medicine's principles of healthcare quality, with the
goal of addressing safety, access, appropriateness, efficiency, effectiveness, and patient centeredness.

5

2.2 | Literature review
Computerized and manual searches were performed to
identify relevant data. Definitions and refinements for
the proposed statements were drawn from guidelines produced by the AAO, ATA, and AHNS-ES. Literature
searches were performed to identify relevant articles in
multiple databases between the years 1972 and 2020,
including the Cochrane Library, EMBASE, PubMed,
Infobase, the Cochrane Central Register of Controlled Trials (CENTRAL), and MEDLINE. Exclusion criteria included
articles that reviewed thyroid or parathyroid surgery without
the mention of voice, swallow, or dyspnea. Search terms
included thyroidectomy, parathyroidectomy, voice, larynx,
VFP, RLN, SLN, flexible laryngoscopy, thyroid surgery, thyroid cancer, stroboscopy, medialization, injection
laryngoplasty, speech language pathology, dysphonia, dysphagia, dyspnea, voice therapy, swallow therapy, FEES,
modified barium swallow, VHI-10, and EAT-10.
Five sections of the Clinical Consensus Statement
outline were divided into subgroups of authors. Their
first phase comprised of a literature review, and communication between a section lead author and coauthors.
The lead author (VKD) collated all submitted sections
into a draft, which was sent to the wider author group for
commentary.
The second phase consisted of two rounds of consensus assessment using the modified Delphi method. The
final recommendation statements and manuscript were
then distributed to members of the AHNS Endocrine
Section leadership for further feedback. After endorsement by the Endocrine Section, it was reviewed by the
AHNS Quality of Care Committee. Once the recommendations from the Quality of Care Committee were incorporated into the manuscript, it received final approval
from the AHNS Council.

2.3 | Modified Delphi method and data
analysis
The modified Delphi method, a previously described and
established method to systematically establish consensus,
was utilized to determine which statements achieved
consensus, near-consensus, or non-consensus.14-16
Through this method, each expert on the panel expressed
his or her opinion for each proposed statement using a
survey. Survey content was developed based on edits to
the initial statement drafts and vetted by three members
of the panel (VKD, RPT, and GWR).
Consensus was achieved in two rounds. In the first
round, the entire expert panel rated six statements. The

6
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Identification

first author (VKD) sent the link to an online survey
(www.qualtrics.com) containing candidate statements
and brief instructions to panel members through email.
Members of the expert panel reviewed proposed statements and independently rated their level of agreement
or disagreement with each, using a Likert scale ranging
from 1 (Strongly Disagree) 9 (Strongly Agree) with five
representing “Neutral” response. Converse statements
were included within the first round survey to serve as
internal controls for participant responses whereby each
statement was followed by its counter statement in the
survey. Panelists could also provide free-text comments
for further discussion, which were recorded. Survey
results were tracked, summarized, and interpreted at
each stage.
During a subsequent teleconference, panel members
discussed the results, focusing on statements that had
engendered comments, a desire for more detail, or suggestions for statement refinement. Discussion revealed
varying interpretations of and suggestions for rewording
five statements. Consequently, the first author (VKD)
modified the statements for review in a second survey.
The results were shared in a subsequent telephone

Records identified through
database searching
(n = 115)

conference call, and the final list of statements was
included within the article.
Statements were defined as achieving consensus if
there was a mean score of 7.00 or greater and 1 or fewer
outlier responses were returned. Near-consensus was
defined as statements with a mean of 6.50 to 6.99 with
two or fewer outliers. No consensus was the default if
these criteria were not met. The basis for achieved consensus with a score of 7 or more is based on Rosenfield
et al.17 Outliers were defined as any rating at least 2 Likert
points away from the mean. Statistical analysis was performed utilizing Stata 12.0 (College Station, Texas).
Mean, SD, median, and interquartile range were calculated according to their standard definitions.

3 | RESULTS
3.1 | Systematic review
A total of 115 articles were reviewed. Eight duplicate articles were removed. Five articles were excluded upon
screening, leaving 102 articles involved in the final meta-

Additional records identified
through other sources
(n = 0)

Eligibility

Screening

Records after duplicates removed
(n = 8)

Records screened
(n = 102)

Full-text articles assessed
for eligibility
(n = 102)

Records excluded
(n = 5)

Full-text articles excluded,
with reasons
(n = 0)

Included

Studies included in
qualitative synthesis
(n = 102)

Studies included in
quantitative synthesis
(meta-analysis)
(n = 102)

F I G U R E 2 Preferred
Reporting Items for Systematic
Reviews and Meta-Analyses
(PRISMA) diagram [Color figure
can be viewed at
wileyonlinelibrary.com]
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TABLE 1
Statement
number (#)

7

Results of panel ratings

Statement verbiage round 1

Mean

Outlier

Statement verbiage round 2

Mean

Outlier

1

The terms transient and permanent
vocal fold paralysis are no longer
sufficient to define varying states
of laryngeal function after thyroid
and parathyroid surgery. Early
identification, visualization and
treatment of immediate
postoperative vocal cord
immobility may allow for
improved patient outcomes.

8.18

2

The terms transient and permanent
vocal fold paralysis do not capture
all varying states of laryngeal
dysfunction that can occur after
thyroid and parathyroid surgery.
Laryngeal dysfunction is complex
and involves more than just
motion impairment. A
comprehensive evaluation in the
immediate postoperative setting is
important if there is concern for
any neural dysfunction.

8.95

0

2

It is appropriate to consider
identification of immediate vocal
fold paralysis within 2 weeks and
2 months postoperatively, or even
earlier if there is knowledge or
concern for vocal fold paralysis
intraoperatively.

8.22

2

Early identification, visualization,
and treatment of immediate
postoperative neural dysfunction
of the vocal fold, including
motion impairment, may allow
for improved patient outcomes.
Vocal fold examination should be
performed in the immediate
postoperative period, which
generally occurs within 2 weeks
to 2 months.

8.90

0

3

Nerve injury can effect afferent and
efferent pathways along a
spectrum of dysfunction and may
be partial but still may lead to
postoperative morbidity. Such
partial neural dysfunction can be
challenging to diagnose.

8.82

0

Laryngeal nerve injury can affect
afferent and efferent pathways,
resulting in a spectrum of
dysfunction. Partial neural
dysfunction includes nonvoice
complaints and therefore may be
underdiagnosed. Clinicians
should have a high index of
suspicion for partial neural
dysfunction and involve
otolaryngology and speech
language pathology colleagues
who may perform a voice and
nonvoice evaluation, as well as
direct visualization of the larynx if
symptoms do not resolve within
2 weeks to 2 months
postoperatively.

8.82

0

4

Partial neural dysfunction of the
larynx is underdiagnosed and
should be identified through
symptom assessment that
includes voice and nonvoice
evaluation, we well as direct
visualization of the larynx if
symptoms do not resolve within
2 weeks to 2 months
postoperatively

8.5

0

A standardized approach in the
workup for patients with
immediate vocal fold paralysis
and partial neural dysfunction
should include an objective voice
and swallow evaluation through
validated questionnaires, direct
visualization of the larynx as well
as further testing if indicated.
Such testing may include
videostroboscopy, laryngeal
electromyography, and modified
barium swallow evaluation.

8.95

0

(Continues)
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TABLE 1
Statement
number (#)

(Continued)

Statement verbiage round 1

Mean

Outlier

Statement verbiage round 2

Mean

Outlier

5

A standardized approach in the
work up for patients with
immediate vocal fold paralysis
and partial neural dysfunction
should include an objective voice
and swallow evaluation through
validated questionnaires, direct
visualization of the larynx, and
further testing if indicated.

8.73

0

Videostroboscopy provides
important information for
patients with immediate vocal
fold paralysis and partial neural
dysfunction. This may apply to
those whose voice evaluation and
symptom assessment are
discordant from preliminary
laryngoscopy findings, as well as
those with documented neural
dysfunction with or without voice
complaints, including states of
SLN dysfunction.

9.00

0

6

Videostroboscopy provides
important information and allows
for improved patient counseling
and treatment planning for
patients with immediate VFP
whose voice evaluation and
symptom assessment are not
consistent with fiberoptic
laryngoscopy findings, as well as
those with documented partial
neural dysfunction who have no
voice complaints.

8.23

4

analysis and inclusion within the article (Figure 2). There
are no previously published consensus statements or clinical practice guidelines with the same search terms.

3.2 | Modified Delphi results
Twenty-two panelists completed both rounds of surveys.
In the first round, consensus was achieved on three statements, near consensus was achieved on two statements
and no consensus was achieved on one statement. At the
completion of the second round, consensus was achieved
on all five revised statements. Table 1 provides the results
of both rounds of panel ratings.

3.2.1 | Statement 1: immediate vocal fold
paralysis
The terms transient and permanent VFP do not capture
all varying states of laryngeal dysfunction that can occur
after thyroid and parathyroid surgery. Laryngeal dysfunction is complex and involves more than just vocal fold
motion impairment. A comprehensive evaluation in the
immediate postoperative setting is important if there is

concern for any neural dysfunction. We therefore introduce the term “immediate” vocal fold paralysis.
VFP that occurs in the immediate postoperative setting has clinical implications regardless of prognosis for
recovery.8 Impaired glottic closure caused by unilateral
VFP in the immediate postoperative period can lead to
significant functional deficits including communication
impairment, dyspnea, and dysphagia. Bilateral VFP in
the immediate postoperative period can lead to airway
compromise and the need for emergent intervention
(Table 2).
The manifestations of unilateral VFP cause immediate impairment of patients' basic life functions and have
a substantial impact on quality of life.9 Dysphonia is the
most common symptom, with rates of voice disturbance
following thyroidectomy ranging from 30% to 87%.18 Dysphagia has been reported in 55% to 69% of patients with
VFP,11-13 resulting in aspiration pneumonia in up to
6%.11 Although less well recognized, dyspnea is also a
common symptom in unilateral VFP, with a reported
prevalence as high as 76%.18 Proposed causes of dyspnea
include hyperventilation19 and passive medialization of
the flaccid vocal fold with inspiration resulting from
laryngeal airflow and turbulence.20-23 For athletes, musicians including singers, and those with high exertional
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TABLE 2

9

Rationale for Immediate VFP definition

• It is our ethical obligation to provide the best patient care-we
need to ask and know what deficits our patients' experience,
and address them.
• As surgeons, it is important to identify and address
complications and improve on our outcomes.
• Nerve injury is more optimally treated when diagnosed
early.
• If we address VFP in the early postoperative period, we can
reduce morbidity and improve quality of life.
• It is clinically pertinent to substantiate the neural
dysfunction for VFP especially if bilateral, as this diagnosis
can indicate observation in the form of humidified air,
racemic epinephrine, steroids, Heliox, and other supportive
treatment versus need for tracheostomy.

activity, this outcome would be debilitating. The psychosocial impact of VFP and its associated symptoms has
been shown to lead to decreased quality of life for
patients. Patients are more likely to file for short-term
disability and experience frustration, isolation, and
altered self-identity as a result of their inability to effectively communicate.9,24,25
The identification of an immediate VFP enables early
intervention in the form of patient counseling, voice therapy, and early medialization procedures if indicated. For
those who undergo treatment, several studies have demonstrated improvement of both dysphagia and dysphonia with
early initiation of speech therapy, as well as injection
laryngoplasty.13,26-31 Injection laryngoplasty significantly
reduces the rate of aspiration, returning patients to a regular
diet.32-39 Patients with unilateral VFP who undergo early
injection laryngoplasty are less likely to require long-term
medialization procedures in the form of thyroplasty than
those who did not receive early injection laryngoplasty.40
Investigations of treatments, like nimodipine in the acute
period of VFP, are promising but requires further evaluation before being widely adopted.41,42 The early involvement of an Otolaryngologist-Head and Neck Surgeon and
Speech Language Pathologist is key in the decision-making
process for early intervention.

3.2.2

|

Statement 2: early identification

Early identification, visualization, and treatment of
immediate post-operative neural dysfunction of the vocal
fold, including vocal fold motion impairment, may allow
for improved patient outcomes. Vocal fold examination
in all of these patients should be performed in the immediate postoperative period, which generally occurs within
2 weeks to 2 months.

In the early postoperative period, a high clinical suspicion for unilateral VFP is important if the patient complains of a weak voice or has an audible breathy quality
to the voice. It is also important to consider that voice
changes may become more apparent after laryngeal
edema improves within a few days of extubation.
The following intraoperative scenarios are consistently
associated with immediate VFP and should be confirmed
and documented by flexible laryngoscopy: (a) known transection or sacrifice of the RLN, or (b) no response to stimulation of the vagus or RLN with the use of nerve monitoring
at the end of surgery. The specificity of electromyography
loss of signal in postoperative VFP detection is 99.9%.43
Patients with known or suspected VFP, independent
of symptoms, should undergo immediate evaluation and
intervention even while admitted following thyroid or
parathyroid surgery. Direct visualization of immediate
VFP assists in (a) identification and documentation of the
VFP, (b) intervention in a prompt fashion, and
(c) counseling of patients with or without symptoms.
Bilateral VFP following thyroidectomy requires early
identification and if necessary, intervention, due to the
risk of airway obstruction. Any patient with stridor following a thyroidectomy requires immediate airway evaluation. Patients with bilateral VFP on direct visualization
and more subtle airway symptoms may be managed conservatively with temporizing measures such as humidified air, racemic epinephrine, corticosteroids, and Heliox,
while patients with more severe symptoms may require a
tracheostomy or a vocal fold lateralization procedure in
the early period. The long-term care of patients with
bilateral VFP may not require surgical intervention but
involves initial and close follow-up once diagnosed.

3.3 | Preoperative laryngeal examination
considerations for patients undergoing
thyroid and parathyroid surgery
Various national44 and international guidelines45,46 recommend preoperative laryngeal evaluation in certain
circumstances—namely, when there are preoperative voice
changes, in high-risk patients such as those with prior neck
or chest surgery, or in cases of thyroid malignancy.18 One
recent paper looked retrospectively at nearly 6000 patients,
and found preoperative VFP in 41 patients (0.68%). Certain
clinical parameters were found to be clinically significant
indicators of VFP and were recommended as part of a
selective approach to preoperative laryngoscopy.47
Preoperative laryngeal examination may be considered
in all patients undergoing thyroid and parathyroid surgery for a number of reasons: (a) There is significant
divergence between voice symptoms and objective vocal

10
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fold function. The sensitivity of voice change in
predicting VFP ranged from 33% to 68% in two studies.48,49 (b) Preoperative recognition of VFP is essential
for surgical planning, such that there may be an incidental vocal fold anomaly that could worsen after surgery. In
one study, almost 60% of patients who underwent preoperative laryngeal evaluation showed an abnormality
(though none had a full paralysis).50 Finally,
(c) preoperative vocal fold function is necessary before

T A B L E 3 Partial neural (motor and sensory) dysfunction after
thyroid surgery (clinical signs and symptoms)
Motor dysfunction
• RLN—paresis, loss of tone,
change in mucosal wave,
paradoxical motion/
laryngospasm, medial
rotation of the arytenoid
• SLN (external branch)—
change in pitch elevation,
fine tuning of voice
• Pharyngeal plexus—
dysphagia, loss of
cricopharyngeal tone,
globus sensation
a

Sensory dysfunction
• RLN—loss of cervical
esophageal sensation,
dysphagia, cough
• aSLN (internal branch)—
cough, globus sensation

The internal branch of the SLN (IBSLN) is not typically at direct
risk during thyroid or parathyroid surgery except for a few
exceptions.

FIGURE 3

assuming responsibility for paralysis found after surgery,
from a medicolegal standpoint.

3.3.1 | Statement 3: partial neural
dysfunction
Laryngeal nerve injury can affect afferent and efferent
pathways, resulting in a spectrum of dysfunction. Partial
neural dysfunction includes non-voice complaints and
therefore may be underdiagnosed. Clinicians should have
a high index of suspicion for partial neural dysfunction
and involve Otolaryngology-Head and Neck Surgery and
Speech Language Pathology colleagues if symptoms persist within 2 weeks to 2 months postoperatively, who
may perform a voice and nonvoice evaluation, as well as
direct visualization of the larynx.
Patients with partial neural dysfunction may present
with perceived changes to swallowing or voicing, even in
the absence of vocal fold immobility.51-53 We define these
as disorders of efferent or afferent pathways of the RLN
or SLN exclusive of VFP seen on preliminary laryngoscopy, all of which may be clinically symptomatic.
Partial neural dysfunction can be into either efferent
(motor) or afferent (sensory) nerve dysfunction, related
to the RLN or SLN nerve fibers (Table 3). Figure 3 demonstrates the biocontinuum for which these afferent and
efferent fibers can lead to related symptoms.

Biocontinuum of states of partial neural dysfunction [Color figure can be viewed at wileyonlinelibrary.com]
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Damage to the efferent or afferent nerves that supply
the larynx and pharynx can be hard to quantify, and motor
and sensory problems often coexist. There is no clear documentation of incidence in the literature, and partial neural
dysfunction may be widely underdiagnosed.

3.4 | Motor Dysfunction
Efferent dysfunction of the RLN can cause motor abnormalities such as VFP in addition to more subtle clinical
changes to nerve function resulting in paresis, defined as
a hypomobile vocal fold due to a neurogenic etiology.54
Literature on vocal fold paresis underscores that there is
a spectrum of possible vocal fold motion impairment.
Therefore, subtle changes due to axonal damage may not
always be immediately evident on laryngeal examination,
but repetitive phonation often reveals sluggish motion of
the affected fold or a perceived asymmetry between vocal
folds on abduction and adduction.55,56
The symptoms associated with vocal fold paresis, like
paralysis, consist of a breathy voice quality and/or vocal
fatigue,57 as well as impaired cough and aspiration due to
incomplete glottic closure, which can significantly impact
quality of life.58 It should be noted that not all motor dysfunction of the larynx is related to a reduced or absent
motion; laryngospasm, paradoxical vocal fold motion,
and airway obstruction have also been described.21,22
Efferent dysfunction of the external branch of the SLN
(EBSLN) primarily affects the cricothyroid muscle, which
is classically thought to be the only muscle innervated by
the SLN. Although the external SLN may contribute efferent fibers to other intrinsic laryngeal muscles,59-61 the primary effect of damage to the SLN's external branch is loss
of cricothyroid muscle function, which causes decreased
vocal range and loss of higher pitches.62-64
Efferent function to the muscles of the pharynx,
upper esophagus, and strap muscles can also be impacted
after thyroidectomy causing varying degrees of dysphagia, throat tightness, or globus sensation. It is known that
many patients experience subjective and objective
swallowing impairment.61,65,66 There can be objective stasis of food in the oropharynx and hypopharynx,67 which
may also relate to afferent function, and esophageal
motility and upper esophageal pressure are also impaired
in some patients.68

3.5 | Sensory dysfunction
Both the RLN and internal branch of the superior laryngeal nerve (IBSLN) have afferent branches to the larynx,
pharynx and cervical esophagus. The IBSLN is purely a
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sensory nerve, which is not typically at direct risk during
thyroid or parathyroid surgery except in a minority of
cases that may include large goiters extending into the
parapharyngeal space or ectopic parathyroid disease.
However, injury to the afferent fibers of the RLN injury
can lead to decreased sensory function, which predisposes patients to coughing, aspiration, irritable throat
sensation, and loss of sensation of the cervical esophagus
leading to dysphagia.67-72 It is also important to consider
sensory abnormalities from the afferent fibers in patients
unilateral VFP. For example, patients with unilateral
VFP do not usually aspirate unless there is also a sensory
deficit.

3.5.1 | Statement 4: standardized
approach
A standardized approach in the work up for patients with
immediate VFP and partial neural dysfunction should
include an objective voice and swallow evaluation
through validated questionnaires, direct visualization of
the larynx as well as further testing if indicated. Such
testing may include videostroboscopy, laryngeal electromyography, and a modified barium swallow evaluation.
Visualization of the larynx and pharynx is a critical
next step in evaluation of partial neural dysfunction.
Stroboscopy is useful in the evaluation of voice complaints or cough related to paresis and glottic insufficiency, as well as possible EBSLN injury73,74 (see
section IV). Laryngeal electromyography (LEMG) has
been suggested as useful in patients with voice complaints57,58 especially when glottic configuration on laryngoscopy and stroboscopy appears normal but weakness
is suspected.74 It should be noted, however, that LEMG is
not a reliable indicator of RLN injury, and EMG abnormalities are not common across the population.35,75,76

Implications and logistics of the laryngeal examination
Per the current guidelines by the American Thyroid
Association,44 as well as the American Academy of Otolaryngology and AHNS,18,77 the timeline suggested in
assessment of immediate voice complaints is between
2 weeks to 2 months after surgery. Within this recommendation, voice assessment should include subjective
patient reporting and an objective assessment of voice by
an Otolaryngologist-Head and Neck Surgeon and Speech
Language Pathologist. A more practical approach, and
one that would allow intervention for patients with
immediate VFP and symptoms of partial neural dysfunction, would be to recommend a laryngeal exam generally
within 2 weeks to 2 months, unless there is suspicion for
neural dysfunction before 2 weeks' time.
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Objective voice and swallow evaluation
A standardized assessment approach is invaluable to
assess immediate dysphonia and dysphagia following
surgery.
Phonatory dysfunction is heterogeneous based on the
range of possible injuries to the RLN or EBLSN as well as
the patient's individual voice use and standards
(Figure 3).63,78,79 The Voice Handicap Index (VHI-10) is a
validated questionnaire used to measure vocal handicap
in the adult population80 and can be used in postthyroidectomy and parathyroidectomy patients with
dysphonia. We propose initial screening with the VHI-10
questionnaire for suspected EBSLN dysfunction. If patients
do not feel their symptoms are adequately assessed via the
provided screening questions, we propose selected additional questions to clarify possible symptoms, adopted from
the validated Singing Voice Handicap Index-10 (SVHI-10,
Figure 4).81 Patients with VHI-10 scores of 11 or greater,82
or positive answers to one or more of our adjunctive
EBSLN questions, warrant referral to an OtolaryngologistHead and Neck Surgeon and Speech Language Pathologist
for further vocal assessment.
While the reported immediate postoperative rates of
dysphagia are as high as 80%, approximately 17% of
patients will have persistent dysphagia complaints at
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6-months after surgery.83 The Eating Assessment Tool
(EAT-10) is a symptom-specific outcome instrument for
dysphagia that can screen patients following thyroidectomy or parathyroidectomy for swallow dysfunction.84-86
In addition to symptom questionnaires, instrumental
diagnostics allow for evaluation of the structural composition and physiologic integrity of the swallowing mechanism. Such diagnostics include fiberoptic endoscopic
evaluation of swallowing (FEES) and videofluroscopic
swallow studies (VFSS). FEES can evaluate for premature
spillage, laryngeal penetration, aspiration, and retention
of material in the oropharynx and hypopharynx,67,87 as
well as allow for real-time counseling on compensatory
strategies and maneuvers to improve swallow safety.87,88
VFSS uses barium in varying consistencies and volumes,
to allow for 2D anatomical and physiologic kinematic
assessment of the oral preparatory, oral, pharyngeal, and
upper esophageal phases of the swallow.89

3.5.2 |

Statement 5: videostroboscopy

Videostroboscopy provides important information for
patients with immediate VFP and partial neural dysfunction. This may apply to those whose voice evaluation and

F I G U R E 4 Algorithm for objective assessment of voice and swallowing complaints after thyroid and parathyroid surgery. EAT-10,
Eating Assessment Tool; EBSLN, external branch superior laryngeal nerve; FEES, fiberoptic endoscopic evaluation of swallowing; IONM,
Intraoperative neuromonitoring; LEMG, laryngeal electromyography; LOS, loss of signal; SVHI, Singing Voice Handicap Index; VFSS,
Videofluoroscopic Swallow Study; VFP, vocal fold paralysis; VHI, Voice Handicap Index; SLP, speech language pathology
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symptom assessment are discordant from preliminary laryngoscopy findings, as well as those with documented
neural dysfunction with or without voice complaints,
including states of SLN dysfunction.

Laryngeal examination
There are four contemporary techniques available that
can be performed in the clinic setting for routine anatomical assessment of the larynx. These include indirect
“mirror” laryngoscopy, laryngeal ultrasound, transnasal
fiberoptic laryngoscopy, and stroboscopy. Performance of
all these approaches necessitates some degree of training.
Transnasal fiberoptic laryngoscopy is the most reliable approach for observing laryngeal function, and is
recognized as the most appropriate means for direct visualization of the larynx.90-92 Fiberoptic laryngoscopy uses
a halogen light source and allows for direct visualization
of any mass/lesions as well as abduction and adduction
of the vocal folds. It is typically easy to perform and well
tolerated by most patients.
Laryngeal stroboscopy can provide information on
vocal fold function that may not be reconciled with laryngoscopy alone. By using a synchronized flashing light,
stroboscopy creates a pseudo-slow motion examination of
the mucosal wave and vocal fold vibrations.56,93 This
enables increased insight into subtle pathological findings such a mucosal wave abnormalities, lesions along
the medial edge of the vocal fold, vocal fold paresis, or
mild asymmetries in abduction and adduction of the
vocal fold and incomplete glottis closure.
One survey of post-fellowship-trained laryngologists
suggests that 72% rely on stroboscopy to diagnose vocal
fold paresis, favoring it over other forms of laryngoscopy
or LEMG.94,95 In paresis, common stroboscopic findings
include vocal fold bowing (70%), incomplete closure
(62%), and increased vibratory amplitude (38%).96 Isolated EBSLN denervation may result in deviation of the
epiglottic petiole to the side of cricothyroid muscle weakness during high-pitched voice production, or as vocal
fold bowing and shortening, vocal process height asymmetry, and ipsilateral hyperadduction of the false vocal
fold.3,73,97,98 Furthermore, patients with complaints such
as cough, globus, or dysphagia with our without voice
complaints should undergo stroboscopy to evaluate for
partial neural dysfunction that may include EBSLN
dysfunction.
A comprehensive laryngeal examination is important to assess laryngeal dysfunction over an extended
period of time, with the use of task specific exercises.
This can involve a multidisciplinary team led by an
Otolaryngologist-Head and Neck Surgeon and a Speech
Language Pathologist.
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Patient counseling and importance of patient outcomes
For patients with VFP or paresis, counseling often
focuses on prognosis for improvement and treatment
options for voice handicap. Of those who will recover
motion, 85% will have recovered within 6 months and
95% will have recovered within 9 months of onset.73
However, as demonstrated by one study, voice outcomes
did not necessarily equate to recovery of VFP.97 The
laryngology-specific follow-up of the patients in this
study may have led to improved voice outcomes simply
by provision of patient counseling. This study also reinforces the role of correlating voice outcomes with visualization of the vocal fold in order to prevent a false sense
of vocal fold recovery if dysfunction was documented
postoperatively.
Early recognition of laryngeal dysfunction, whether it
be RLN or SLN injury, and whether it be a VFP or partial
neural dysfunction, leads to improved patient counseling
with the appropriate specialists in Otolaryngology-Head
and Neck Surgery as well as Speech Language Pathology.8,51,99-102 Patient counseling is beneficial and
independent of the need for further treatment. Close
follow-up or decided upon treatment options can mitigate
delays in care and unnecessary reduction in patient quality of life.77

4 | CONCLUSION
The terms “immediate” vocal fold paralysis and “partial
neural dysfunction” are important when identifying
laryngeal dysfunction after thyroid and parathyroid surgery. Partial neural dysfunction is equally as important as
immediate IVFP because both the efferent and afferent
pathways of the RLN and efferent fibers of the SLN
(EBSLN) can lead to persistent and treatable voice and
non-voice related symptoms. Objective assessment of
symptoms and laryngeal examination in the form of laryngoscopy is a recommended starting point, with consideration of stroboscopy when preliminary laryngoscopy
does not explain the patient's symptoms. The role of an
experienced and trained Otolaryngologist-Head and Neck
Surgeon and Speech Language Pathologist is crucial in
the assessment, counseling, and consideration of treatment options.
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